Do you want to read an article? Please log in or register.
Sleep disturbance and sleep insufficiency in primary caregivers and their children with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
Medication Use, Sleep, and Caregiver Smoking Status Among Urban Children with Asthma
J Asthma.
Miadich SA, Everhart RS, Heron KE, Cobb CO
doi: 10.1080/
Pulmonary Fibrosis
Pancreatic Insufficiency in Cystic Fibrosis: Influence of Inflammatory Response Genes
Pancreas.
Marson FAL, Bertuzzo CS, de Araujo TK, Hortencio TDR, Ribeiro AF, Ribeiro JD
doi: 10.1097/
Pulmonary Fibrosis
Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency
J Cyst Fibros.
Thursfield RM, Naderi K, Leaver N, Rosenthal M, Alton EWFW, Bush A, Davies JC
doi: 10.1016/j.jcf.2018.02.011.
RECOMMENDED
Pulmonary Fibrosis
Sleep-disordered breathing and markers of morbidity in children and adolescents with cystic fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol.
Barbosa RRB, Liberato FMG, de Freitas Coelho P, Vidal PDR, de Carvalho RBCO, Donadio MVF
doi: 10.1002/ppul.24780.
CoughPulmonary Fibrosis
The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial
Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT
doi: 10.1016/
RECOMMENDED
Pulmonary Fibrosis
Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Cheney J, Vidmar S, Gailer N, Wainwright C, Douglas TA, Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group.
doi: 10.1016/j.jcf.2020.02.022.
RECOMMENDED
Pulmonary Fibrosis
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
Lancet Respir Med.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS
doi: 10.1016/S2213-2600(18)30460-0.
RECOMMENDED
Pulmonary Fibrosis
Sleep disorders in cystic fibrosis: A systematic review and meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Sleep Med Rev.
Reiter J, Gileles-Hillel A, Cohen-Cymberknoh M, Rosen D, Kerem E, Gozal D, Forno E
doi: 10.1016/j.smrv.2020.101279.
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
Lancet Respir Med.
Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group
doi: 10.1016/S2213-